| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8735375 | Hepatobiliary & Pancreatic Diseases International | 2017 | 8 Pages |
Abstract
Basiliximab may be effective in reducing de novo diabetes mellitus. What is more, basiliximab in combination with steroids-free immunosuppressant shows statistical benefit to reduce biopsy-proven acute rejection and de novo hypertension.
Related Topics
Health Sciences
Medicine and Dentistry
Hepatology
Authors
Guo-Qing Zhang, Cheng-Shuo Zhang, Ning Sun, Wu Lv, Bao-Min Chen, Jia-Lin Zhang,